Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer

Olivier Bylicki Nicolas Paleiron 1 Jacques Margery Florian Guisier 2 Alain Vergnenegre 3 Gilles Robinet 4 Jean-Bernard Auliac Radj Gervais 5 Christos Chouaid 6
1 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale
2 Service de pneumologie, oncologie thoracique et soins intensifs respiratoires [Rouen]
3 Service de Pathologie respiratoire et allergologie [CHU Limoges]
4 CHU - BREST - Hôpital de la Cavale Blanche - CHRU Brest
5 CRLC François Baclesse - Centre Régional de Lutte contre le Cancer François Baclesse
6 Service de Pneumologie [CHI Créteil]
Document type :
Journal articles
Complete list of metadatas
https://hal.univ-brest.fr/hal-02048079
Contributor : Ghislaine Calvez <>
Submitted on : Monday, February 25, 2019 - 1:31:45 PM
Last modification on : Thursday, July 25, 2019 - 2:24:48 PM

Identifiers

  • HAL Id : hal-02048079, version 1

Collections

UNIV-BREST | GETBO | COMUE-NORMANDIE | UNIROUEN | IBSAM

Citation

Olivier Bylicki, Nicolas Paleiron, Jacques Margery, Florian Guisier, Alain Vergnenegre, et al.. Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer. Targeted Oncology, Springer Verlag (Germany), 2017, 12 (5), pp.563-569. ⟨hal-02048079⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

23

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD